Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53

被引:52
作者
Cinatl, J
Kotchetkov, R
Scholz, M
Cinatl, J
Vogel, JU
Driever, PH
Doerr, HW
机构
[1] Univ Frankfurt Klinikum, Zentrum Hyg, Inst Med Virol, D-60528 Frankfurt, Germany
[2] Univ Frankfurt Klinikum, Zentrum Kinderheilkunde & Jugendmed, Abt Padiatr Hamatol & Onkol, D-60528 Frankfurt, Germany
[3] Georgetown Univ, Med Ctr, Dept Neurosurg, Washington, DC 20007 USA
关键词
D O I
10.1016/S0002-9440(10)65122-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Thrombospondin-1 (TSP-1) is a potent inhibitor of angiogenesis. It has been shown that promoter sequences of the TSP-1 gene can be transactivated by the wild-type tumor suppressor protein p53. As human cytomegalovirus (HCMV) infection inactivates wildtype p53 of various cell types, we investigated whether HCMV infection is associated with reduced TSP-1 production. We found, in conjunction with accumulated p53, that TSP-1 mRNA and protein expression was significantly reduced in HCMV-infected cultured human fibroblasts. To determine whether the observed TSP-1 suppression depends on p53 inactivation, the p53-defective astrocytoma cell line U373MG was infected with HCMV. In these cells TSP-1 expression was also significantly reduced by HCMV infection whereas expression of the p53 mutant variant remained unaltered. In both cell lines the decreased expression of TSP-1 mRNA occurred early after infection (4 hours), indicating that HCMV inhibits TSP-1 transcription during the immediate-early phase of infection before HCMV DNA replication, Inhibition of HCMV DNA synthesis by ganciclovir did not influence TSP-1 reduction whereas the antisense oligonucleotide ISIS 2922, complementary to HCMV immediate-early mRNA, completely prevented the HCMV-mediated TSP-1 suppression. These findings strongly suggest a novel role for HCMV in the modulation of angiogenesis due to p53-independent down-regulation of TSP-1 expression.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 54 条
[1]  
ALBRECHT T, 1993, FRONTIERS VIROLOGY, V2, P384
[2]   INDUCTION OF AN ENDOTHELIAL-CELL GROWTH-FACTOR BY HUMAN CYTOMEGALOVIRUS-INFECTION OF FIBROBLASTS [J].
ALCAMI, J ;
BARZU, T ;
MICHELSON, S .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :2765-2770
[3]   Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA [J].
Anderson, KP ;
Fox, MC ;
BrownDriver, V ;
Martin, MJ ;
Azad, RF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) :2004-2011
[4]   ANTIVIRAL ACTIVITY OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE COMPLEMENTARY TO RNA OF THE HUMAN CYTOMEGALOVIRUS MAJOR IMMEDIATE-EARLY REGION [J].
AZAD, RF ;
DRIVER, VB ;
TANAKA, K ;
CROOKE, RM ;
ANDERSON, KP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1945-1954
[5]   SPECIFIC-INHIBITION OF ENDOTHELIAL-CELL PROLIFERATION BY THROMBOSPONDIN [J].
BAGAVANDOSS, P ;
WILKS, JW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (02) :867-872
[6]   Vascular development: Cellular and molecular regulation [J].
Beck, L ;
DAmore, PA .
FASEB JOURNAL, 1997, 11 (05) :365-373
[7]  
Bertin N, 1997, CANCER RES, V57, P396
[8]   ACTIVATION OF PROTO-ONCOGENES - AN IMMEDIATE EARLY EVENT IN HUMAN CYTOMEGALOVIRUS-INFECTION [J].
BOLDOGH, I ;
ABUBAKAR, S ;
ALBRECHT, T .
SCIENCE, 1990, 247 (4942) :561-564
[9]   INCREASED LEVELS OF SEQUENCE-SPECIFIC DNA-BINDING PROTEINS IN HUMAN CYTOMEGALOVIRUS-INFECTED CELLS [J].
BOLDOGH, I ;
FONS, MP ;
ALBRECHT, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (03) :1505-1510
[10]  
BORDOW SB, 1994, CANCER RES, V54, P5036